KORU Medical Systems Inc (KRMD) is now in the Overvalued zone, suggesting that its current forward PS ratio of 5.69 is considered Overvalued compared with the five-year average of -45.60. The fair price of KORU Medical Systems Inc (KRMD) is between 2.73 to 4.58 according to relative valuation method. Compared to the current price of 4.87 USD , KORU Medical Systems Inc By Overvalued By 6.23%.

Relative Value

Fair Zone

2.73-4.58

Current Price：4.87

6.23%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is KORU Medical Systems Inc (KRMD) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

KORU Medical Systems Inc (KRMD) has a current Price-to-Book (P/B) ratio of 15.77. Compared to its 3-year average P/B ratio of 7.31, the current P/B ratio is approximately 115.71% higher. Relative to its 5-year average P/B ratio of 5.91, the current P/B ratio is about 166.90% higher. KORU Medical Systems Inc (KRMD) has a Forward Free Cash Flow (FCF) yield of approximately -0.07%. Compared to its 3-year average FCF yield of -2.68%, the current FCF yield is approximately -97.50% lower. Relative to its 5-year average FCF yield of -3.57%, the current FCF yield is about -98.13% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for KRMD competitors is 2.65, providing a benchmark for relative valuation. KORU Medical Systems Inc Corp (KRMD.O) exhibits a P/S ratio of 5.69, which is 114.41% above the industry average. Given its robust revenue growth of 27.17%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of KRMD increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of KRMD in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is KRMD currently overvalued or undervalued?

What is KORU Medical Systems Inc (KRMD) fair value?

KRMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of KORU Medical Systems Inc (KRMD) is between 2.73 to 4.58 according to relative valuation method.

How does KRMD's valuation metrics compare to the industry average?

The average P/S ratio for KRMD's competitors is 2.65, providing a benchmark for relative valuation. KORU Medical Systems Inc Corp (KRMD) exhibits a P/S ratio of 5.69, which is 114.41% above the industry average. Given its robust revenue growth of 27.17%, this premium appears sustainable.

What is the current P/B ratio for KORU Medical Systems Inc (KRMD) as of Mar 03 2026?

As of Mar 03 2026, KORU Medical Systems Inc (KRMD) has a P/B ratio of 15.77. This indicates that the market values KRMD at 15.77 times its book value.

What is the current FCF Yield for KORU Medical Systems Inc (KRMD) as of Mar 03 2026?

As of Mar 03 2026, KORU Medical Systems Inc (KRMD) has a FCF Yield of -0.07%. This means that for every dollar of KORU Medical Systems Inc's market capitalization, the company generates -0.07 cents in free cash flow.

What is the current Forward P/E ratio for KORU Medical Systems Inc (KRMD) as of Mar 03 2026?

As of Mar 03 2026, KORU Medical Systems Inc (KRMD) has a Forward P/E ratio of -448.80. This means the market is willing to pay $-448.80 for every dollar of KORU Medical Systems Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for KORU Medical Systems Inc (KRMD) as of Mar 03 2026?

As of Mar 03 2026, KORU Medical Systems Inc (KRMD) has a Forward P/S ratio of 5.69. This means the market is valuing KRMD at $5.69 for every dollar of expected revenue over the next 12 months.

KRMD Valuation